HEALTH & AI
WEEKLY ARTICLES
In-depth articles exploring how AI is transforming healthcare, for everyday people and the professionals who care for them. A new issue every Wednesday.
Latest issue
We're back ! | The 'Robot Referee': How AI Could Approve Your Treatment in Seconds Before a Human Ever Reads Your Chart
This week, three headlines told one story. Newly released records from Medicare's AI-assisted prior authorization pilot revealed thousands of denials and requests left waiting for weeks. An analysis from the Blue Cross Blue Shield Association found that AI documentation and coding tools added nearly $1 billion in hospital charges without any matching rise in treatment. And in Minnesota, roughly 150 physicians walked off the job, partly to win a say over how AI shapes their decisions. Together, they point to an algorithmic arms race over the medical bill, with patients caught in the middle. This article explains how the "Robot Referee" works, what HIPAA, PIPEDA and Europe's new rules do (and don't) protect, and what patients and professionals can do about it.
Previous issues
The 'Walking Terabyte': How Unlocking Your Own Fragmented Data Could Save Your Life
For decades, patient health data has been trapped in a labyrinth of disconnected silos—wearables tracking heart rates, patient portals holding lab results, and pharmacy apps hoarding medication histories. This week, a wave of major announcements, spearheaded by Microsoft's launch of Copilot Health and next-generation AI-powered continuous biometric monitors, signaled the arrival of the "Consumer AI Health Companion." This article explores how synthesizing fragmented personal health data into a single, unified AI space is transforming preventative care, the shifting perspectives of physicians embracing this technology, and the complex privacy hurdles involving HIPAA and PIPEDA that must be overcome to protect our most intimate digital footprint.
Goodbye Chatbots, Hello Coworkers: The 'Agentic' Surge That’s Replacing Search Bars with Surgical Precision
This week marks a paradigm shift in healthcare as "Agentic AI" moves from experimental pilots to clinical reality. Highlighting the launch of the first autonomous biotech agents and the FDA’s approval of AI-enabled surgical imaging, we explore how specialized AI "teams" are outperforming single-agent systems. As Canada finalizes its renewed National AI Strategy and the EU streamlines its AI Act for medical devices, the industry is transitioning from "chatbots that talk" to "agents that act," promising a 65% reduction in compute costs while dramatically increasing diagnostic accuracy.
How AI Decodes a Newborn's Silent Cry for Help Before the Fever Hits
This week’s feature examines a groundbreaking shift in neonatal care: the use of "Ambient AI" and microbial cell-free DNA (mcfDNA) sequencing to detect infectious diseases in newborns. By moving beyond traditional blood cultures to "Digital Biomarkers," clinicians are now able to identify life-threatening sepsis and respiratory complications up to 48 hours before physical symptoms manifest, fundamentally changing the survival trajectory for the world’s most vulnerable patients.
The 'Invisible Surgeon': How System-Wide AI Could Fix Wait Times Before You Even Book an Appointment
As global healthcare systems grapple with historic provider shortages, a new wave of "System-Wide AI" is moving beyond simple diagnostics to redesigning the entire patient journey. From the FDA’s latest surge in AI-enabled device clearances to new WHO guidelines on digital health equity, this week marks a shift from experimental "pilot" programs to integrated, sovereign health-AI infrastructure.
The 'Genetic Crystal Ball': How AI Could Save Your Newborn's Life Before They Even Show a Symptom
A new wave of AI-driven genomic screening is transforming neonatal care, moving from the standard "heel prick" to rapid Whole Genome Sequencing (rWGS) capable of detecting thousands of rare diseases in hours. Major initiatives like the BEACONS project and BabyFORce are piloting this technology on over 30,000 newborns, promising to identify treatable conditions before symptoms arise. However, this "genetic crystal ball" raises critical privacy concerns under PIPEDA and HIPAA regarding data ownership and the potential for genetic discrimination.
How AI Could Rescue Unborn Babies Before Mothers Even Show a Bump
A groundbreaking AI tool launched this week promises to detect fetal growth restriction in the first trimester by analyzing placental blood flow, shifting the paradigm from reactive management to proactive prevention. This article explores the technology, the clinical implications for brain development, and the privacy challenges of digitizing unborn life.
The 'Time Machine' in Your Skull: How a New AI 'Brain Age' Scan Could Save Your Mind Before You Even Lose It
A groundbreaking "foundation model" for brain imaging, developed by Mass General Brigham, can now predict dementia risk, tumor survival, and "brain age" from routine MRIs with unprecedented accuracy. Unlike previous single-task AIs, this "BrainIAC" model represents a shift toward generalist medical intelligence, offering a glimpse into a future where a single scan could decode a patient's entire neurological trajectory before symptoms ever appear.
The 'Virtual You': How a Digital Twin Could Save Your Life Before You Even Get Sick
This week in 2026, the concept of the "Digital Twin" has officially moved from engineering labs to the hospital bedside. New breakthroughs from Western University and the University of Michigan are enabling doctors to test treatments on virtual replicas of patients before prescribing them to the real thing. This article explores how this shift toward "in silico" medicine is ending the era of trial-and-error healthcare, while new global alliances like LIGAND-AI accelerate drug discovery. Finally, we examine the critical privacy battle lines drawn between Canada’s PIPEDA and the USA’s HIPAA as our biological data moves to the cloud.
How AI Is Rewriting Breast Cancer Screening
AI in breast cancer screening is shifting from “Is it accurate?” to “How should health systems redesign reading pathways safely?” as large prospective studies and pragmatic trials test AI-assisted reading at population scale. This week’s focus: how AI-enabled screening could reduce radiologist workload and callbacks while raising new governance questions about safety thresholds, equity, and regulation across Canada, the U.S., Europe, Asia, and the Middle East.
Get each new article by email
One email when a new Health & AI Weekly article goes live. No spam, and you can unsubscribe in one click.
We'll send a confirmation link first. See our privacy policy.